Vir Biotechnology Inc (VIR)
10.00
+5.37%
Vir Biotechnology Inc (VIR) is currently trading at $10.00. This represents a gain of 5.37% from the previous session. With a market capitalization of $1.40B, VIR is a key component of the Health Care sector. Investors looking to trade VIR should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade VIR commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Vir Biotechnology Inc (VIR) shows a bullish trend. Analysts are watching the 10.94 level closely.
Fundamentals
Mkt Cap1.40B
P/E Ratio0.0000
Volume10,230,588
60-Day Technical Chart
Advanced Charting
Need more indicators for VIR? Use the world's #1 platform.
Open VIR on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $10
| Metric |
VIR +5.37% |
IBRX -17.40% |
ONDS -0.96% |
PATH -1.54% |
|---|---|---|---|---|
| Price | $10.00 | $9.54 | $10.30 | $9.94 |
| Mkt Cap | $1.40B | $9.81B | $4.35B | $5.32B |
| - | View → | View → | View → |
Latest Headlines
Vir Biotech Catapults On Its $1.71 Billion Deal With Astellas
Investor's Business Daily • Feb 24, 2026
What’s Happening With VIR Stock?
Forbes • Feb 24, 2026
Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results
TIKR.com • Feb 25, 2026
Vir Biotechnology Announces Proposed Public Offering of Common Stock
Yahoo Finance • Feb 24, 2026
Vir Biotechnology Stock Pre-Market (+58%) : Landmark Astellas Deal & Positive Cancer Data
Trefis • Feb 24, 2026
● Gemini Agentic AI Analyst Insight for VIR
Market Education
- Large Cap at Lowest Price Apr 9, 2024
- October Market Volatility: Why Investors Fear the “Danger Month” Sep 26, 2025
- Want to be a Wall street billionaire, take their investing advice Jul 19, 2023
External Research